Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Should Recombinant Activated Factor VII (NovosevenTM) Be Given to Acute ICH Patients without an FDA Approved Indication?

Should Recombinant Activated Factor VII (NovosevenTM) Be Given to Acute ICH Patients without an FDA Approved Indication?. 2004.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.